drug discovery bio-venture aiming at practical application of advanced research such as cell therapy .
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 11, 2020 | Series B | ¥700M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Okasan Capital Partners | — | Series B |